European Myelodysplastic Syndromes Cooperative Group
EMSCO AT A GLANCE
The European Myelodysplastic Syndromes Cooperative Group (EMSCO) serves as a platform to foster academic clinical research, cooperation and education in the field of myelodysplastic syndromes (MDS).
EMSCO is administered by GWT-TUD GmbH and was founded in 2013 upon an initiative of the European Leukemia Network (ELN). Originally founded to facilitate European MDS-specific trials, EMSCO soon also became active in organising indication-specific conferences and in serving as a platform for education and outreach in MDS.